RainDance | GenomeWeb


The company has scaled back its headcount from a peak of 115 employees to about 100 staff members, primarily on the commercial side.

The UCSF-based Blood Systems Research Institute will conduct research using RainDance's digital PCR platforms as part of a new $20 million amfAR Institute for HIV Cure Research.

The work identified specific groups of somatic mutations that might be ideal to hunt for in ctDNA to monitor tumor burden, guide treatment, or follow therapeutic response.

The company filed to go public in March with plans to offer up to $60 million of its stock. 

The company has established a streamlined workflow that customizes and automates key steps of the sample prep process.

The solutions will combine RainDance's digital droplet technology and single-molecule barcoding technology with PacBio's proprietary long-range DNA amplification technology.

The agreements are to distribute RainDance's products in Central and Eastern Europe, Italy, Switzerland, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.

The firm said that it plans to list its stock on the Nasdaq under ticker symbol "RAIN" and added that its 2014 revenues were up 78 percent year over year to $30.6 million.

The plaintiffs accuse 10X, a synthetic long-read technology firm, of infringing six patents covering methods of conducting reactions within microfabricated substrates.

An increasing number of publications using droplet-based digital PCR platforms suggests acceptance and uptake of the technology.


In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.